Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mylan Inc.
With
Theravance Biopharma
Age
18–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
For renal impairment group:
Subject has severe renal impairment (eGFR \<30 mL/min/1.73 m2)
For normal renal function group:
Subject is in good health
You may not be if
Women who are pregnant, lactating, breastfeeding, or planning to become pregnant during the study.
Subject has received an investigational drug (or medical device) within 30 days
Subject who, for any reason, is deemed by the investigator to be inappropriate for this study; or has any condition that would confound or interfere with the evaluation of the safety, tolerability, or PK of the investigational drug; or is unable to comply with the study protocol.
